Welcome to the Utah Medical Association

The Utah Medical Association (UMA) was established in 1895 as both a means of sharing and promoting scientific advancements in medicine and allowing social interaction among colleagues. Over the decades since its inception, UMA has evolved into the state's foremost advocacy arm for the profession, protecting and enhancing the environment in which medicine is practiced in Utah, while providing membership benefits to assist in the day to day practice of the profession.

To apply for membership online, first CREATE a logon account, then you can JOIN via the online membership application. If you prefer to join via a paper application, click here.

CREATE LOGON      JOIN UMA!

Log In:

Education for Controlled Substance Prescribers

Required Course for License Renewal

In Utah, legislation was passed that requires health care providers licensed to prescribe controlled substances to complete 3.5 hours of Department of Occupational and Professional Licensing (DOPL) approved continuing education on Schedule II and III controlled substances that are applicable to opioid narcotics, hypnotic depressants, and psychostimulants. (Utah Code Section 58-37-6.5) This required education is intended to reduce the negative effects of controlled substances in Utah.

The UMA Foundation course, CONTROLLED SUBSTANCES: EDUCATION FOR THE PRESCRIBER, is approved by DOPL and available online. You may take the course in one sitting or incrementally and at your convenience from work, home, or any location with internet access. Click here to get instructions on how to begin the registration process or to re-access the course.

Note: In addition to this course, DOPL requires controlled substance prescribers to complete the thirty-minute Controlled Substance Database (CSD) tutorial and examination. This is the same DOPL course that you have already been taking every two years for licensure renewal.

Hydrocodone Combo Products Now Schedule II Drugs

The Drug Enforcement Administration (DEA) recently published a final rule (PDF) in the Federal Register rescheduling hydrocodone combination products to Schedule II of the Controlled Substances Act (CSA). The DEA’s rationale for the move is to combat prescription drug abuse. As these drugs were previously in Schedule III, this change has dramatically increased the restrictions on prescribing and dispensing practices for hydrocodone combination products. The rule went into effect October 6, 2014. UMA members should identify patients being treated with hydrocodone combination products and change prescribing practices to conform to the drugs’ more restrictive Schedule II requirements.

This change will affect prescription refills as follows: As of October 6, 2014, Hydrocodone combination prescriptions may not authorize any refills. A new prescription must be written by the prescriber if the patient requires continued therapy.

No content found

No content found

UMA Events

November 2017


December 2017

  • 1
     Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Fibromyalgia:  Updates and Management Tips for Clinicians, SLC, UMAF (4.0)

September 2018

  • 14-15
    2018 UMA House of Delegates, Location TBD